Literature DB >> 9790441

Human cystic echinococcosis in a Uruguayan community: a sonographic, serologic, and epidemiologic study.

H Cohen1, E Paolillo, R Bonifacino, B Botta, L Parada, P Cabrera, K Snowden, R Gasser, R Tessier, L Dibarboure, H Wen, J C Allan, H Soto de Alfaro, M T Rogan, P S Craig.   

Abstract

A prevalence and transmission study of human cystic echinococcosis (CE), due to infection with the dog tapeworm Echinococcus granulosus, was undertaken in the village of La Paloma in central Uruguay. The human population was registered and screened for CE by abdominal ultrasound scan as well as a number of serologic tests. Dogs were screened for E. granulosus infection by arecoline purgation as well as specific coproantigen testing. The total prevalence of human CE (new cases and those with a previous history) was 5.6% (64 of 1,149); 3.6% (40) of the cases were new ultrasound detected asymptomatic cases (mean age = 45 years). Age prevalence increased from 1.1% in the 4-6-year-old group to > 11% in the > 60-year-old group; the 20-29-year-old group had a significantly higher CE rate of 7.4%, compared with younger and older age groups, and there was no difference between sexes. A CE rate of 3.9% (20 of 514) was also recorded by ultrasound for new cases in the population residing outside the village. Most of the hydatid cysts were located in the liver presenting as either univesicular cysts or a solid mass, and of those 71% and 63%, respectively, with such cyst presentations were seropositive against E. granulosus cyst fluid antigens. Two of eight individuals who were filter paper blood spot seropositive, but ultrasound scan negative, were subsequently diagnosed respectively with pulmonary hydatidosis after radiography, and hepatic hydatidosis after computed tomography scan. Of 36 households with a CE patient, 32 were single cases while four households each harbored two CE cases. This did not represent a clustered distribution within families (23 of 117). Almost 20% of the dogs from La Paloma were found infected with E. granulosus after purge examination, with a mean worm number of 67 (range = 1-1,020). An additional eight dogs that were purge negative were Echinococcus coproantigen positive. The study showed that human CE is highly endemic in Uruguay, with one of the highest local prevalence rates in the world. Transmission appears to occur readily within well-developed towns, as well as on rural sheep ranches. Mass screening by ultrasound scanning with confirmatory serologic testing is an effective approach to case detection at the community level.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9790441     DOI: 10.4269/ajtmh.1998.59.620

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  24 in total

1.  Palanivelu hydatid system for safe and efficacious laparoscopic management of hepatic hydatid disease.

Authors:  C Palanivelu; R Senthilkumar; K Jani; P S Rajan; K Sendhilkumar; R Parthasarthi; S Rajapandian
Journal:  Surg Endosc       Date:  2006-12       Impact factor: 4.584

Review 2.  Cavitary pulmonary disease.

Authors:  L Beth Gadkowski; Jason E Stout
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

Review 3.  A systematic review of the literature on cystic echinococcosis frequency worldwide and its associated clinical manifestations.

Authors:  Christine M Budke; Hélène Carabin; Patrick C Ndimubanzi; Hai Nguyen; Elizabeth Rainwater; Mary Dickey; Rachana Bhattarai; Oleksandr Zeziulin; Men-Bao Qian
Journal:  Am J Trop Med Hyg       Date:  2013-04-01       Impact factor: 2.345

Review 4.  Hepatic echinococcosis: clinical and therapeutic aspects.

Authors:  Giuseppe Nunnari; Marilia R Pinzone; Salvatore Gruttadauria; Benedetto M Celesia; Giordano Madeddu; Giulia Malaguarnera; Piero Pavone; Alessandro Cappellani; Bruno Cacopardo
Journal:  World J Gastroenterol       Date:  2012-04-07       Impact factor: 5.742

5.  Serological diagnosis of lung cystic hydatid disease using the synthetic p176 peptide.

Authors:  Saul J Santivañez; Patricia Arias; Milagrytos Portocarrero; Silvia Rodriguez; Armando E Gonzalez; Robert H Gilman; Cesar M Gavidia; Hector H Garcia
Journal:  Clin Vaccine Immunol       Date:  2012-04-18

6.  Treatment of liver hydatidosis: how to treat an asymptomatic carrier?

Authors:  Bernardo Frider; Edmundo Larrieu
Journal:  World J Gastroenterol       Date:  2010-09-07       Impact factor: 5.742

7.  Cystic echinococcosis in Jordan: socioeconomic evaluation and risk factors.

Authors:  M A Nasrieh; S K Abdel-Hafez; S A Kamhawi; P S Craig; P M Schantz
Journal:  Parasitol Res       Date:  2003-05-28       Impact factor: 2.289

Review 8.  Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern.

Authors:  Johannes Eckert; Peter Deplazes
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

9.  Spillage-free laparoscopic management of hepatic hydatid disease using the hydatid trocar canula.

Authors:  Kalpesh Jani
Journal:  J Minim Access Surg       Date:  2014-07       Impact factor: 1.407

10.  Specific IgG responses to recombinant antigen B and em18 in cystic and alveolar echinococcosis in china.

Authors:  Tiaoying Li; Akira Ito; Xingwang Chen; Yasuhito Sako; Jiamin Qiu; Ning Xiao; Dongchuan Qiu; Minoru Nakao; Tetsuya Yanagida; Philip S Craig
Journal:  Clin Vaccine Immunol       Date:  2009-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.